Source:http://linkedlifedata.com/resource/pubmed/id/15738294
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-3-1
|
pubmed:abstractText |
Bronchiolitis obliterans syndrome (BOS) is a severe complication after lung transplantation (LTX). In a retrospective cohort study 12 stable healthy recipients (non-BOS) and eight patients with BOS were enrolled after LTX and matrix metalloproteinases (MMP)-9, TIMP-1 and cell characteristics in bronchoalveolar lavage (BAL) samples (n = 145) were analysed. BALs from patients with BOS were further divided according to whether they were obtained before (pre-BOS) or after manifestation of BOS (BOS group). The MMP-9/TIMP-1 ratio was significantly increased in the BOS group compared with non-BOS or pre-BOS; furthermore, the ratio was negatively correlated with forced expiratory volume in one second. In zymography, the active form of MMP-9 was detected predominantly in the BOS group. In addition, zymography showed the banding pattern of neutrophil-derived MMP-9, indicating that polymorphonuclear neutrophils (PMNs) were the main source of MMP-9. According to that, MMP-9 was significantly correlated with the number of PMN. In immunocytochemistry, MMP-9 was also associated predominantly with PMN. This is the first study to evaluate the expression of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 over time during manifestation of a fibroproliferative lung disease in patients. It demonstrates development of bronchiolitis obliterans syndrome after lung transplantation is associated with an imbalance of matrix metalloproteinases-9/tissue inhibitors of metalloproteinase-1 ratio.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
494-501
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15738294-Adult,
pubmed-meshheading:15738294-Bronchiolitis Obliterans,
pubmed-meshheading:15738294-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:15738294-Cell Count,
pubmed-meshheading:15738294-Cohort Studies,
pubmed-meshheading:15738294-Female,
pubmed-meshheading:15738294-Humans,
pubmed-meshheading:15738294-Lung Transplantation,
pubmed-meshheading:15738294-Male,
pubmed-meshheading:15738294-Matrix Metalloproteinase 9,
pubmed-meshheading:15738294-Middle Aged,
pubmed-meshheading:15738294-Neutrophils,
pubmed-meshheading:15738294-Reference Values,
pubmed-meshheading:15738294-Respiratory Function Tests,
pubmed-meshheading:15738294-Retrospective Studies,
pubmed-meshheading:15738294-Tissue Inhibitor of Metalloproteinase-1
|
pubmed:year |
2005
|
pubmed:articleTitle |
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
|
pubmed:affiliation |
Dept of Internal Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schittenhelmstr.12, 24105 Kiel, Germany. rhuebner@1med.uni-kiel.de
|
pubmed:publicationType |
Journal Article,
Comparative Study
|